Company intelligence / Profile preview
IGY Life Sciences
- Ownership
- Private
- Employees
- ~18
- Development stage
- Other
Overview
IGY Life Sciences has developed a proprietary process to extract high-purity IgY antibodies from chicken egg yolks. Their lead programs include preclinical-stage intranasal IgY therapies against influenza and coronavirus as well as discovery-stage oral therapy for celiac disease. Their non-specific IgYs are already commercialized in the nutraceutical sector under the brand Muno-IgY™, which recently achieved self-GRAS status in the US. The company’s manufacturing facility operates at GMP standards with capacity for both small and large batch production.
- Therapeutic areas
- GastroenterologyImmunologyInfectious Diseases
- Modalities
- AntibodyBiologic
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on IGY Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IGY Life Sciences.